MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611058619 A) filed by Manipal University Jaipur on May 08, 2026, for A Blockchain-Based Medicine Supply Chain Verification System For Detection And Prevention Of Counterfeit Medicines.
Inventor includes Dr. Amit Chaurasia.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention relates to a blockchain-based medicine supply chain verification system. The system comprises a smart contract deployed on a decentralized blockchain network, a role-based access control module assigning roles including Manufacturer, Distributor, Wholesaler, Retailer, and Regulator, and a participant registry for managing authorized addresses, wherein a batch creation module records medicine batch details and generates a deterministic batch identifier using cryptographic hashing of predefined parameters, a transfer recording module maintains an append-only history including sender, receiver, timestamp, and optional data, a verification module provides batch existence, composite validity based on recall status, counterfeit flag, and expiry, and current holder, a recall control module enables a regulator to assign an irreversible recall status preventing further transfers, and a counterfeit flagging mechanism permits any address to report suspected counterfeit batches with associated reasons, thereby ensuring secure, transparent, and tamper-evident traceability across the supply chain.
Disclaimer: Curated by HT Syndication.
